Tao Jiang

Neoadjuvant Camrelizumab Plus Platinum-Based Chemotherapy vs Chemotherapy Alone for Chinese Patients With Resectable Stage IIIA or IIIB (T3N2) Non–Small Cell Lung Cancer

Jie Lei, Jinbo Zhao, Li Gong et al. · JAMA Oncology · 2023 · 98 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Neoadjuvant Pembrolizumab and Chemotherapy in Resectable Esophageal Cancer: An Open-Label, Single-Arm Study (PEN-ICE)

Hongtao Duan, Changjian Shao, Minghong Pan et al. · Frontiers in Immunology · 2022 · 54 citations · Full text

Medicine, Oncology, Surgery +17

Circ-HSP90A expedites cell growth, stemness, and immune evasion in non-small cell lung cancer by regulating STAT3 signaling and PD-1/PD-L1 checkpoint

Jie Lei, Jianfei Zhu, Bengang Hui et al. · Cancer Immunology Immunotherapy · 2022 · 39 citations · Full text

Medicine, Cancer Biology, Oncology +17

A multicenter, single-arm, open study of neoadjuvant or conversion atezolizumab in combination with chemotherapy in resectable small cell lung cancer (Cohort Study)

Hongtao Duan, Liang Shi, Changjian Shao et al. · International Journal of Surgery · 2023 · 20 citations · Full text

Medicine, Oncology, Pharmacotherapy +12

62MO A randomised, controlled, multicenter phase II trial of camrelizumab combined with albumin-bound paclitaxel and cisplatin as neoadjuvant treatment in locally advanced NSCLC

Jie Lei, Xiaolong Yan, Jian Zhao et al. · Annals of Oncology · 2020 · 19 citations

Medicine, Oncology, Pharmacology +14